Authors
Latest:
The Evolving Value Assessment Landscape in the USHow current frameworks influence coverage decisions and pricing negotiations.
Latest:
What Makes Hub Programs Successful?Outlining the core functional skill sets of the most effective hub programs—all toward the goal of helping patients get on prescriptions as quickly as possible
Latest:
Telehealth: Connecting the DotsHow pharma can speed up the journey with direct-to-patient models
Latest:
Maximizing HCP engagement as the definition of a sales ‘call’ expandsHow pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization
Latest:
After a Decade of Regulatory Transformation, What’s Next?Following a decade of solid groundwork to modernize regulatory information management in life sciences, leading companies have now shifted their focus to how they might exploit this new digital landscape
Latest:
Merck's 21-Valent Pneumococcal Conjugate Vaccine Shows Efficacy Across Various SerotypesThe FDA previously granted priority review to a biologics license application for V116 as a single dose for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.
Latest:
Succeeding with Fit-for-Purpose AIHow artificial intelligence is improving the patient experience
Latest:
Drug Shortages: A Chronic Problem, but New Opportunities Present ThemselvesWhile this concern is causing ripples in the global supply chain, technological and regulatory advances can help address the issue
Latest:
Developing a Successful Data & Analytics Strategy: Four Common QuestionsA comprehensive data and analytics strategy is now table stakes for pharmaceutical and life science organizations, writes Simon Andrews
Latest:
The Impact of 340B on Commercial ContractsDuplicate rebates have resulted in revenue leakage for manufacturers.
Latest:
Congress Leaves Town with Major Drug-Related Bills on HoldPandemic preparedness and curbing PBMs among the pending legislation that will have to wait until after summer recess.
Latest:
What’s Next for Biopharma Under the Inflation Reduction ActAs we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry.
Latest:
Positioning the Patient in Drug TrialsThe clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials
Latest:
Developing Your Roadmap to Pharma 4.0Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.
Latest:
Exploring the Digital Therapeutics LandscapeObservations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton
Latest:
What is a Digital Hub in 2023?Deciphering the different "technology-first” and “technology-enabled” patient support programs.
Latest:
Seeing the Value of Scientific ContentLeveraging the value healthcare professionals place on scientific content
Latest:
Strategizing High-Wire, Multi-Indication LaunchesProperly supporting market access for a newly launched product with a single indication is challenging. Doing so for multiple indications, or supporting subsequent indications, can have a compounding effect on the degree of difficulty for getting everything right.
Latest:
Chatbot Potential in Clinical ResearchHow AI-powered support automation can solve the data problem in clinical trial management
Latest:
Is Trust the Secret Ingredient for Digital Product Success?To rebuild trust, companies should utilize a customer-centric approach, focusing on transparent and neutral content incorporating medical expertise and regularly seeking HCP feedback.
Latest:
Global Logistics: A Cold Chain BlueprintThe growing pipeline of cold chain products holds tremendous promise for patients, but can result in failed shipments if not properly planned for
Latest:
Flipping the Switch on DSCSA InteroperabilityFrom November 2023, the Drug Supply Chain Security Act requires healthcare manufacturers, distributors, providers, and dispensers to exchange the serialized item-level product information that has been collected, standardized, and digitized. Hitting this deadline hinges on intensive collaboration between manufacturers and their supply chain partners that must begin now
Latest:
No More Excuses: It’s Time to Invest in the PharmacyOrganizations can go a long way toward ushering in the pharmacy of the future and enabling safer, more efficient care by implementing an intelligent infrastructure of technology.
Latest:
Five powerful Covid-related shifts in patient careThe biggest areas of adjustment in patient support brought on by changes in consumer and physician behavior
Latest:
Rethinking NCPs in support mixNon-commercial pharmacies can be secret weapons for intake and adherence
Latest:
The Opportunity for SustainabilityPharma’s prime chance to reduce carbon emissions from supply chain
Latest:
Achieving Efficient, Optimized, and Compliant Production at ScaleInnovation in pharma manufacturing as paradigms shift and biotech and personalized therapies move through clinical trials at pace
Latest:
Patient Data: Solving Ownership QuestionHow privacy and technology literacy can coexist behind a blockchain-based approach to patient data analytics and control
Latest:
Creating a Future-Ready Chemicals and Materials Lab Vital for GrowthTeams need to keep close track of ingredients, processing parameters, and material performance so that they can use their R&D data to decide exactly which materials to make next.
